Full text is available at the source.
Abstract
Statins may be associated with sleep disturbances including insomnia and altered sleep quality.
- Clinical and experimental evidence suggests that statin therapy could disrupt sleep architecture and reduce overall sleep quality.
- The gut microbiota may play a critical role in regulating sleep through pathways involving serotonin and melatonin.
- Statins have been shown to alter gut microbial composition, potentially reducing beneficial bacteria that produce short-chain fatty acids.
- Changes in gut bacteria caused by statins may disrupt neurochemical signaling related to sleep regulation.
- The review discusses the implications of these findings for vulnerable populations, such as shift workers.
- Potential strategies, including probiotics and dietary changes, are proposed to address statin-related sleep disturbances.
Simplified